Literature DB >> 2809255

Human ehrlichiosis: prospective active surveillance in febrile hospitalized patients.

D B Fishbein1, A Kemp, J E Dawson, N R Greene, M A Redus, D H Fields.   

Abstract

Between 1 April 1987 and 30 September 1988 prospective active surveillance of human ehrlichiosis was conducted among febrile patients hospitalized in southeast Georgia. If disease of the immune system, bacterial infection, pneumonia, or surgical illness was documented by the end of the first full day of hospitalization, the patient was excluded. Of 75 patients enrolled in the study, 8 (10.7%) had a fourfold rise or fall in titer to Ehrlichia canis (case-patients). The rate was 5.3 cases/100,000 population. Case-patients were more likely than noncase patients to have become ill in May or June (P = .008) and to report a recent tick bite (P less than .001). At hospital admission, case-patients had lower white blood cell counts (median, 4,450/mm3; P = .001), platelet counts (median, 133,000/mm3 P less than .001), and higher aspartate aminotransferase (median, 68 IU/ml; P = .004) and alanine aminotransferase levels (median, 62 IU/ml; P = .038).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2809255     DOI: 10.1093/infdis/160.5.803

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  21 in total

1.  Ehrlichiosis in a visitor to Virginia.

Authors:  R W Armstrong
Journal:  West J Med       Date:  1992-08

2.  Therapy of human ehrlichiosis reconsidered.

Authors:  L L Barton
Journal:  Antimicrob Agents Chemother       Date:  1991-02       Impact factor: 5.191

3.  Immunoblot studies to analyze antibody to the Rickettsia typhi group antigen in sera from patients with acute febrile cerebrovasculitis.

Authors:  K E Hechemy; J A Fox; D H Gröschel; F G Hayden; R P Wenzel
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

4.  Animal model of fatal human monocytotropic ehrlichiosis.

Authors:  E A Sotomayor; V L Popov; H M Feng; D H Walker; J P Olano
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

5.  Antigenic characterization of ehrlichiae: protein immunoblotting of Ehrlichia canis, Ehrlichia sennetsu, and Ehrlichia risticii.

Authors:  P Brouqui; J S Dumler; D Raoult; D H Walker
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

6.  Molecular cloning and characterization of the Ehrlichia chaffeensis variable-length PCR target: an antigen-expressing gene that exhibits interstrain variation.

Authors:  J W Sumner; J E Childs; C D Paddock
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

Review 7.  The tribe Ehrlichieae and ehrlichial diseases.

Authors:  Y Rikihisa
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

Review 8.  Epidemiology of rickettsial diseases.

Authors:  D H Walker; D B Fishbein
Journal:  Eur J Epidemiol       Date:  1991-05       Impact factor: 8.082

9.  Clinical manifestations, epidemiology, and laboratory diagnosis of human monocytotropic ehrlichiosis in a commercial laboratory setting.

Authors:  Juan P Olano; Wayne Hogrefe; Brent Seaton; David H Walker
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

10.  Naturally occurring Ehrlichia chaffeensis infection in two prosimian primate species: ring-tailed lemurs (Lemur catta) and ruffed lemurs (Varecia variegata).

Authors:  Cathy V Williams; Jan L Van Steenhouse; Julie M Bradley; Susan I Hancock; Barbara C Hegarty; Edward B Breitschwerdt
Journal:  Emerg Infect Dis       Date:  2002-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.